Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)
+ A peptide calculator is a research tool that helps calculate precise draw volumes for reconstituted peptides
By three years of age, the microbiome foundation is somewhat established
Conventional activation of the pathway is initiated at the cell surface by the phosphorylation of RTKs in response to mitogen stimulation [10]
Comparing routes helps patients and providers make evidence-based decisions aligned with individual health status
If you experience side effects, your provider is accessible
